A detailed history of Perkins Coie Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Perkins Coie Trust CO holds 529 shares of NVS stock, worth $52,027. This represents 0.01% of its overall portfolio holdings.

Number of Shares
529
Previous 529 -0.0%
Holding current value
$52,027
Previous $56,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

BUY
$94.73 - $105.13 $37,892 - $42,052
400 Added 310.08%
529 $53,000
Q2 2023

Jul 13, 2023

SELL
$92.52 - $104.91 $56,529 - $64,100
-611 Reduced 82.57%
129 $13,000
Q1 2023

Apr 12, 2023

BUY
$80.03 - $92.81 $48,898 - $56,706
611 Added 473.64%
740 $68,000
Q4 2022

Jan 18, 2023

SELL
$75.55 - $92.52 $34,753 - $42,559
-460 Reduced 78.1%
129 $0
Q3 2022

Oct 07, 2022

SELL
$74.61 - $87.26 $5,670 - $6,631
-76 Reduced 11.43%
589 $45,000
Q2 2022

Jul 08, 2022

SELL
$80.52 - $93.75 $31,724 - $36,937
-394 Reduced 37.2%
665 $56,000
Q1 2022

Apr 15, 2022

SELL
$80.11 - $90.62 $69,775 - $78,930
-871 Reduced 45.13%
1,059 $93,000
Q4 2021

Jan 13, 2022

SELL
$79.7 - $88.13 $990,113 - $1.09 Million
-12,423 Reduced 86.55%
1,930 $169,000
Q3 2021

Oct 13, 2021

SELL
$81.78 - $95.14 $820,416 - $954,444
-10,032 Reduced 41.14%
14,353 $1.17 Million
Q2 2021

Jul 14, 2021

BUY
$85.24 - $94.15 $20,798 - $22,972
244 Added 1.01%
24,385 $2.23 Million
Q1 2021

Apr 13, 2021

SELL
$83.5 - $98.47 $25,050 - $29,541
-300 Reduced 1.23%
24,141 $2.06 Million
Q4 2020

Jan 12, 2021

BUY
$78.07 - $94.43 $117,026 - $141,550
1,499 Added 6.53%
24,441 $2.31 Million
Q3 2020

Oct 13, 2020

BUY
$82.14 - $91.0 $17,824 - $19,747
217 Added 0.95%
22,942 $2 Million
Q2 2020

Jul 13, 2020

BUY
$80.93 - $91.1 $83,681 - $94,197
1,034 Added 4.77%
22,725 $1.99 Million
Q1 2020

Apr 10, 2020

SELL
$70.67 - $99.01 $70,316 - $98,514
-995 Reduced 4.39%
21,691 $1.79 Million
Q4 2019

Jan 09, 2020

BUY
$84.35 - $95.37 $99,786 - $112,822
1,183 Added 5.5%
22,686 $2.15 Million
Q3 2019

Oct 11, 2019

BUY
$85.54 - $94.26 $7,698 - $8,483
90 Added 0.42%
21,503 $1.87 Million
Q2 2019

Jul 10, 2019

SELL
$75.4 - $92.8 $35,588 - $43,801
-472 Reduced 2.16%
21,413 $1.96 Million
Q1 2019

Apr 08, 2019

BUY
$75.32 - $86.15 $26,512 - $30,324
352 Added 1.63%
21,885 $2.1 Million
Q4 2018

Jan 15, 2019

BUY
$73.66 - $82.02 $1,104 - $1,230
15 Added 0.07%
21,533 $1.85 Million
Q3 2018

Oct 15, 2018

SELL
$66.94 - $77.43 $803 - $929
-12 Reduced 0.06%
21,518 $1.85 Million
Q2 2018

Jul 17, 2018

BUY
$64.91 - $73.36 $17,006 - $19,220
262 Added 1.23%
21,530 $1.63 Million
Q1 2018

Apr 16, 2018

BUY
$70.39 - $84.15 $46,175 - $55,202
656 Added 3.18%
21,268 $1.72 Million
Q4 2017

Jan 12, 2018

BUY
$72.33 - $77.64 $2,025 - $2,173
28 Added 0.14%
20,612 $1.73 Million
Q3 2017

Oct 13, 2017

BUY
$74.14 - $77.27 $1.53 Million - $1.59 Million
20,584
20,584 $1.77 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Perkins Coie Trust CO Portfolio

Follow Perkins Coie Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.